
201 - 500 employees
Founded 1989
🏥 Healthcare
🧬 Biotechnology
⚕️ Healthcare Insurance
💰 $74.8M Post-IPO Equity on 2018-06
Healthcare • Biotechnology • Healthcare Insurance
Vericel Corporation is a biotechnology company that manufactures and markets advanced cell therapy products aimed at the sports medicine and severe burn care markets in the United States. It offers unique treatments such as MACI for knee cartilage repair and Epicel for burn care, and holds exclusive rights to the biological product NexoBrid for eschar removal of severe thermal burns.
📡 We watch Vericel® Corporation's careers page
Several times a day
how often we check
4
roles posted in the last 30 days
About 57 days
usual time to fill a role
5
roles closed in the last year
Selected: 🆕 Date Added.
🕒 October 23
Senior Medical Director leading UK MACI launch medical affairs and patient safety. Building European KOL networks and expansion strategy for Vericel’s regenerative cell therapies.
🌐 United Kingdom, Germany, +1 more countries – Remote
💰 $74.8M Post-IPO Equity on 2018-06
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
👻 Ghost score 10%
🕒 August 11
Senior MSL advancing Vericel’s regenerative orthopedic cell therapies across the Northeast. Building KOL relationships, supporting clinical evidence generation, and informing Medical Affairs strategy.
🗽 New York, Maryland, +2 more states – Remote
💵 $171k - $195k / year
💰 $74.8M Post-IPO Equity on 2018-06
⏰ Full Time
🟠 Senior
✨ Medical Science Liaison
👻 Ghost score 7%